` SOPH (Sophia Genetics SA) vs S&P 500 Comparison - Alpha Spread

S
SOPH
vs
S&P 500

Over the past 12 months, SOPH has underperformed S&P 500, delivering a return of -22% compared to the S&P 500's +13% growth.

Stocks Performance
SOPH vs S&P 500

Loading
SOPH
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
SOPH vs S&P 500

Loading
SOPH
S&P 500
Difference
www.alphaspread.com

Performance By Year
SOPH vs S&P 500

Loading
SOPH
S&P 500
Add Stock

Competitors Performance
Sophia Genetics SA vs Peers

S&P 500
SOPH
VEEV
PME
DOCS
2413
Add Stock

Sophia Genetics SA
Glance View

Market Cap
248.6m USD
Industry
Health Care

SOPHiA GENETICS SA is a healthcare technology company, which establishes the practice of data driven medicine as the standard of care and for life sciences research. The firm offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The firm has offices in Switzerland, France and the United Kingdom and operates worldwide.

SOPH Intrinsic Value
4.58 USD
Undervaluation 19%
Intrinsic Value
Price
S
Back to Top